Evidence map›Paper›PMID 38183057›Full record

ArticleJournal of biomedical science2024

Localization, traffic and function of Rab34 in adipocyte lipid and endocrine functions.

Jaime López-Alcalá, Ana Gordon, Andrés Trávez, Carmen Tercero-Alcázar, Alejandro Correa-Sáez, María Jesús González-Rellán, Oriol A Rangel-Zúñiga, Amaia Rodríguez, Antonio Membrives, Gema Frühbeck and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomedical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Jaime López-AlcaláDepartment of Cell Biology, Physiology, and Immunology, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba (UCO), Reina Sofía University Hospital (HURS), Córdoba, Spain.
Ana GordonDepartment of Cell Biology, Physiology, and Immunology, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba (UCO), Reina Sofía University Hospital (HURS), Córdoba, Spain. v92becoa@uco.es.
Andrés TrávezDepartment of Cell Biology, Physiology, and Immunology, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba (UCO), Reina Sofía University Hospital (HURS), Córdoba, Spain.
Carmen Tercero-AlcázarDepartment of Cell Biology, Physiology, and Immunology, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba (UCO), Reina Sofía University Hospital (HURS), Córdoba, Spain.
Alejandro Correa-SáezDepartment of Cell Biology, Physiology, and Immunology, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba (UCO), Reina Sofía University Hospital (HURS), Córdoba, Spain.
María Jesús González-RellánCIBER Physiopathology of Obesity and Nutrition (CIBERobn), ISCIII, Madrid, Spain.
Oriol A Rangel-ZúñigaCIBER Physiopathology of Obesity and Nutrition (CIBERobn), ISCIII, Madrid, Spain.
Amaia RodríguezCIBER Physiopathology of Obesity and Nutrition (CIBERobn), ISCIII, Madrid, Spain.
Antonio MembrivesDepartment of Medical-Surgical Specialties, University of Córdoba (UCO), Reina Sofia University Hospital (HURS), Córdoba, Spain.
Gema FrühbeckCIBER Physiopathology of Obesity and Nutrition (CIBERobn), ISCIII, Madrid, Spain.
Rubén NogueirasCIBER Physiopathology of Obesity and Nutrition (CIBERobn), ISCIII, Madrid, Spain.
Marco A CalzadoDepartment of Cell Biology, Physiology, and Immunology, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba (UCO), Reina Sofía University Hospital (HURS), Córdoba, Spain.
Rocío Guzmán-RuizDepartment of Cell Biology, Physiology, and Immunology, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba (UCO), Reina Sofía University Hospital (HURS), Córdoba, Spain.
María M MalagónDepartment of Cell Biology, Physiology, and Immunology, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba (UCO), Reina Sofía University Hospital (HURS), Córdoba, Spain. bc1mapom@uco.es.ORCID http://orcid.org/0000-0002-2419-2727
Instituto Maimónides de Investigación Biomédica de Córdoba · ESInstituto de Salud Carlos III · ESUniversidade de Santiago de Compostela · ESUniversity of Córdoba · ES

Funding

Consejería de Salud y Familias, Junta de Andalucía P20_00470Consejería de Salud y Familias, Junta de Andalucía RH-00532021Consejería de Salud y Familias, Junta de Andalucía RH-00652021EMBO 8855Ministerio de Ciencia e Innovación BFU2016-76711-RMinisterio de Ciencia e Innovación FPI17/BES-2017-081354Ministerio de Ciencia e Innovación PID2019-108403RB-I00Ministerio de Ciencia e Innovación PID2021-124314OB-I00Ministerio de Ciencia, Innovación y Universidades FPU18/00845
6 · The paper itself

Abstract

backgroundExcessive lipid accumulation in the adipose tissue in obesity alters the endocrine and energy storage functions of adipocytes. Adipocyte lipid droplets represent key organelles coordinating lipid storage and mobilization in these cells. Recently, we identified the small GTPase, Rab34, in the lipid droplet proteome of adipocytes. Herein, we have characterized the distribution, intracellular transport, and potential contribution of this GTPase to adipocyte physiology and its regulation in obesity.

methods3T3-L1 and human primary preadipocytes were differentiated in vitro and Rab34 distribution and trafficking were analyzed using markers of cellular compartments. 3T3-L1 adipocytes were transfected with expression vectors and/or Rab34 siRNA and assessed for secretory activity, lipid accumulation and expression of proteins regulating lipid metabolism. Proteomic and protein interaction analyses were employed for the identification of the Rab34 interactome. These studies were combined with functional analysis to unveil the role played by the GTPase in adipocytes, with a focus on the actions conveyed by Rab34 interacting proteins. Finally, Rab34 regulation in response to obesity was also evaluated.

resultsOur results show that Rab34 localizes at the Golgi apparatus in preadipocytes. During lipid droplet biogenesis, Rab34 translocates from the Golgi to endoplasmic reticulum-related compartments and then reaches the surface of adipocyte lipid droplets. Rab34 exerts distinct functions related to its intracellular location. Thus, at the Golgi, Rab34 regulates cisternae integrity as well as adiponectin trafficking and oligomerization. At the lipid droplets, this GTPase controls lipid accumulation and lipolysis through its interaction with the E1-ubiquitin ligase, UBA1, which induces the ubiquitination and proteasomal degradation of the fatty acid transporter and member of Rab34 interactome, FABP5. Finally, Rab34 levels in the adipose tissue and adipocytes are regulated in response to obesity and related pathogenic insults (i.e., fibrosis).

conclusionsRab34 plays relevant roles during adipocyte differentiation, including from the regulation of the oligomerization (i.e., biological activity) and secretion of a major adipokine with insulin-sensitizing actions, adiponectin, to lipid storage and mobilization from lipid droplets. Rab34 dysregulation in obesity may contribute to the altered adipokine secretion and lipid metabolism that characterize adipocyte dysfunction in conditions of excess adiposity.

Indexed as

AdiponectinProteomicsAdipocytesAdipokinesFatty Acid-Binding ProteinsGTP PhosphohydrolasesHumansLipidsObesityAdipokinesAdiponectinFABP5 protein, humanFatty Acid-Binding ProteinsGTP PhosphohydrolasesLipidsAdipocytesAdiponectinGolgi apparatusLipid dropletsLipid metabolismProtein traffickingRab34

Identifiers

PMID38183057
PMCPMC10770960
OpenAlexW4390617475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.